Sign In
Buy DXCM
$72.59
-0.180 (-0.247%)
At Close: Jun 04, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM
10:00am, Wednesday, 25'th Sep 2024
NEW YORK , Sept. 25, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM).
DexCom Is Great. Here's Why You Shouldn't Buy It.
09:45am, Wednesday, 25'th Sep 2024
DexCom seems to be growing fairly consistently, and that could continue. But the competition for its segment is getting fiercer by the quarter.
Is DexCom a Millionaire Maker?
08:07am, Wednesday, 25'th Sep 2024
DexCom could credibly grow at a decent clip for a long period. Its ongoing international expansion is its main growth driver for now.
NEW YORK, NY / ACCESSWIRE / September 25, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
DXCM OCTOBER 21 DEADLINE: DexCom, Inc. has been Sued for Securities Fraud; Contact BFA Law before October 21Court Deadline (Nasdaq:DXCM)
07:13am, Wednesday, 25'th Sep 2024
NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Compa
DXCM Shareholders Have Opportunity to Lead DexCom, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
07:00am, Wednesday, 25'th Sep 2024
NEW YORK CITY, NY / ACCESSWIRE / September 25, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom
NEW YORK, NY / ACCESSWIRE / September 24, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 25
October 21, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - DXCM
04:00pm, Tuesday, 24'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 24, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
October 21, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against DXCM
01:45pm, Tuesday, 24'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 24, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)
01:43pm, Tuesday, 24'th Sep 2024
LOS ANGELES, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 21, 2024 deadline to file a lead plaintiff motion in the class action
RADNOR, PA / ACCESSWIRE / September 24, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed against DexCom,
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom Lawsuit – DXCM
01:05pm, Tuesday, 24'th Sep 2024
NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM).
NEW YORK, NY / ACCESSWIRE / September 24, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fo
DexCom Inc Is Being Sued For Possible Securities Fraud And The Schall Law Firm Urges Investor Participation
11:00am, Tuesday, 24'th Sep 2024
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "the Company") (NASDAQ:DXCM) for violations of 10(b) a
